Laurel Wealth Advisors (North Carolina)’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-80
| Closed | -$6K | – | 613 |
|
|
2022
Q2 | $6K | Hold |
80
| – | – | ﹤0.01% | 432 |
|
|
2022
Q1 | $7K | Hold |
80
| – | – | ﹤0.01% | 446 |
|
|
2021
Q4 | $9K | Hold |
80
| – | – | ﹤0.01% | 424 |
|
|
2021
Q3 | $10K | Hold |
80
| – | – | ﹤0.01% | 416 |
|
|
2021
Q2 | $11K | Hold |
80
| – | – | ﹤0.01% | 454 |
|
|
2021
Q1 | $11K | Buy |
+80
| New | +$11K | ﹤0.01% | 421 |
|